BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Latour M, Her NG, Kesari S, Nurmemmedov E. WNT Signaling as a Therapeutic Target for Glioblastoma. Int J Mol Sci 2021;22:8428. [PMID: 34445128 DOI: 10.3390/ijms22168428] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Żwierełło W, Maruszewska A, Skórka-Majewicz M, Gutowska I. Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours-A Research Hypothesis. Int J Mol Sci 2023;24. [PMID: 36675073 DOI: 10.3390/ijms24021558] [Reference Citation Analysis]
2 S DP, Kuduvalli SS, Biswas I, K B, B AK, Thomas JM, T. S A. Dynamics of repurposing synthetic and natural compounds against WNT/β-Catenin signaling in glioma- Anin vivoapproach.. [DOI: 10.1101/2022.12.02.518940] [Reference Citation Analysis]
3 Goker Bagca B, Ozates NP, Biray Avci C. Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes. Med Oncol 2022;40:37. [PMID: 36460932 DOI: 10.1007/s12032-022-01897-4] [Reference Citation Analysis]
4 Chen B, Li X, Wu L, Zhou D, Song Y, Zhang L, Wu Q, He Q, Wang G, Liu X, Hu H, Zhou W. Quercetin Suppresses Human Glioblastoma Migration and Invasion via GSK3β/β-catenin/ZEB1 Signaling Pathway. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.963614] [Reference Citation Analysis]
5 Swati K, Agrawal K, Raj S, Kumar R, Prakash A, Kumar D. Molecular mechanism(s) of regulations of cancer stem cell in brain cancer propagation. Med Res Rev 2022. [PMID: 36205299 DOI: 10.1002/med.21930] [Reference Citation Analysis]
6 Drakulic D, Schwirtlich M, Petrovic I, Mojsin M, Milivojevic M, Kovacevic-grujicic N, Stevanovic M. Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. Cells 2022;11:2530. [DOI: 10.3390/cells11162530] [Reference Citation Analysis]
7 Lombardi F, Augello FR, Artone S, Ayroldi E, Giusti I, Dolo V, Cifone MG, Cinque B, Palumbo P. Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype. Front Oncol 2022;12:933746. [DOI: 10.3389/fonc.2022.933746] [Reference Citation Analysis]
8 Yusuf S, Aretz P, Nickel A, Westhoff P, Sharma A, Qin N, Remke M, Steiger H, Hänggi D, Liu H, Liu H, Neumann S, Reifenberger G, Maciaczyk J. WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells. Cancers 2022;14:3165. [DOI: 10.3390/cancers14133165] [Reference Citation Analysis]
9 Majchrzak-celińska A, Kleszcz R, Studzińska-sroka E, Łukaszyk A, Szoszkiewicz A, Stelcer E, Jopek K, Rucinski M, Cielecka-piontek J, Krajka-kuźniak V. Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. Cells 2022;11:1084. [DOI: 10.3390/cells11071084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. Int J Mol Sci 2022;23:1545. [PMID: 35163465 DOI: 10.3390/ijms23031545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chernov AN, Shamova OV. Molecular mechanisms of drug resistance of glioblastoma. Part 1: ABC family proteins and inhibitors. Medical academic journal 2021;21:85-106. [DOI: 10.17816/maj83049] [Reference Citation Analysis]